July 31, 2026 · Form 4 insider transaction
Uihlein Richard E bought 31,825,235 shares of Galectin Therapeutics Inc. at $3.00 per share, a transaction worth $95.48M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.